Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Postoperative Delirium in Elderly Hip Fracture
NCT06443957Completed
- Sponsor
- The First Hospital of Jilin University
- Start
- Jul 2023
- Primary completion
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of Generex Oral-lyn in postoperative delirium (POD) (3 arms), sponsored by The First Hospital of Jilin University. Primary endpoint: Incidence of Postoperative Delirium at Day 3. Started Jul 2023; status: completed.
02
Drugs
Generex Oral-lyn
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT06443957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06443957.